Showing results (141-150 of 190) with videos related to

Sort By:
Pageof 19
Oncotarget|February 9, 2018
Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse modelsKei Kawaguchi, Kentaro Igarashi, Shukuan Li, et al.
Tissue & Cell|August 1, 2018
Doxorubicin-resistant pleomorphic liposarcoma with PDGFRA gene amplification is targeted and regressed by pazopanib in a patient-derived orthotopic xenograft mouse modelTasuku Kiyuna, Takashi Murakami, Yasunori Tome, et al.
Cell Cycle (Georgetown, Tex.)|January 16, 2018
Regorafenib regresses an imatinib-resistant recurrent gastrointestinal stromal tumor (GIST) with a mutation in exons 11 and 17 of c-kit in a patient-derived orthotopic xenograft (PDOX) nude mouse modelKentaro Miyake, Kei Kawaguchi, Tasuku Kiyuna, et al.
Medical Physics|April 28, 2021
Prediction of soft tissue sarcoma response to radiotherapy using longitudinal diffusion MRI and a deep neural network with generative adversarial network-based data augmentationYu Gao, Vahid Ghodrati, Anusha Kalbasi, et al.
BMC Cancer|August 22, 2018
Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse modelTasuku Kiyuna, Yasunori Tome, Takashi Murakami, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 4, 2023
ASHP and ASHP Foundation Pharmacy Forecast 2024: Strategic Planning Guidance for Pharmacy Departments in Hospitals and Health SystemsJoseph T DiPiro, James M Hoffman, Pamela Schweitzer, et al.
Anticancer Research|May 6, 2020
Recombinant Methioninase Combined With Tumor-targeting Salmonella typhimurium A1-R Induced Regression in a PDOX Mouse Model of Doxorubicin-resistant Dedifferentiated LiposarcomaKentaro Igarashi, Kei Kawaguchi, Ming Zhao, et al.
Cancer Chemotherapy and Pharmacology|February 14, 2019
Regorafenib regressed a doxorubicin-resistant Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude mouse modelKentaro Miyake, Tasuku Kiyuna, Kei Kawaguchi, et al.
Cell Cycle (Georgetown, Tex.)|December 1, 2017
Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and preventionKei Kawaguchi, Qinghong Han, Shukuan Li, et al.
Cancer Genomics & Proteomics|April 30, 2020
A Novel Anionic-phosphate-platinum Complex Effectively Targets a Cisplatinum-resistant Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse ModelKentaro Igarashi, Kei Kawaguchi, Norio Yamamoto, et al.
Pageof 19